A14-039

PhD BS.

Phạm Quốc Thắng

Department of Pathology

Rating:
0/5
(0 rating)
Rating:
0/5
(0 rating)
Professional philosophy

I believe that pathology is the heart of precision medicine, where histomorphology and molecular biology converge to illuminate the nature of disease. As a pathologist, I not only aim for accurate diagnosis but also wish to help decipher the mechanisms of carcinogenesis, thereby improving prognosis and individualizing treatment for patients. 

I see training a new generation of young pathologists as a mission, contributing to building a stronger, more modern, and humane Vietnamese medical foundation

Patient's feeling
0/5
(0 rating)

Write your review

Rating:
Choose rating

Patient rating

No review

Expertise
Molecular Pathology
Cancer Research
Cell Biology
Education
  • 2021: Doctor of Medicine, specialization in Biomedical Science, Hiroshima University - Hiroshima - Japan
  • 2016: Master of Medicine, specialization in Morphological Medicine, University Medical Center Ho Chi Minh City. 
  • 2012: General Medicine Doctor, University Medical Center Ho Chi Minh City. 
Experience

Kinh nghiệm giảng dạy

  • 2013 - present: Lecturer at the University Medical Center Ho Chi Minh City. 

Kinh nghiệm khám, chữa bệnh

  • 2014 - present: Physician at the Department of Pathology, University Medical and Pharmacy Hospital, Ho Chi Minh City. 
Associations
  • Member - Ho Chi Minh City Pathology Society
  • Member - Vietnam Society of Cellular Pathology
  • Member - The Japanese Society of Pathology
  • Associate member - American Association for Cancer Research
  • Member - Japanese Cancer Association
  • Member - United States and Canadian Academy of Pathology
Awards

Awarded for achievements in international publications with impact factor (IF) ≥ 3 during the 2023-2025 period

Research
  • 2023 Survey of RET gene mutations in medullary thyroid carcinoma
  • 2024 Study of PD-L1 expression in invasive urothelial carcinoma of the bladder
  • 2025 Survey of pathological features of newly formed surface corneal epithelial papilloma
  • 2025 Study of TRK protein expression in colorectal cancer with microsatellite instability.
  • 2022 Research on molecular phenotype subtyping of bladder cancer using immunohistochemistry